Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Bone Density × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hepatoblastoma 1 Endometrial Neoplasms 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 47 Magnetic Resonance Spectroscopy 47 enzalutamide 41 Prednisone 34 apalutamide 32 Androgen Antagonists 30 Abiraterone Acetate 29 Leuprolide 25 darolutamide 24 Radiotherapy 22 Radiosurgery 21 Docetaxel 21 abiraterone 19 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 17 relugolix 16 Biopsy 16 X-Rays 14 Radiation 14 Pluvicto 14 Goserelin 14 cabazitaxel 13 prednylidene 11 luprolide acetate gel depot 11 deltacortene 11 bicalutamide 11 Triptorelin Pamoate 11 Glutamate Carboxypeptidase II 11 Carboplatin 11 gallium 68 PSMA-11 10 Gonadotropin-Releasing Hormone 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05838716 2026-01-15

ViPER

University of Rochester

Phase 3 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡